Publications by authors named "Zhanye Liu"
DNA-damaging agents, such as doxorubicin (Adriamycin), are widely used for the treatment of small cell lung cancer (SCLC). However, drug resistance is one of the major challenges for treatment of SCLC. Herein, we investigated the mechanisms underlying drug resistance in SCLC cells and the effects of resveratrol (Res) on drug resistance.
View Article and Find Full Text PDFNon-small cell lung cancer (NSCLC) is the most common tumor affecting modern people and is associated with severe morbidity and high mortality. Exosomal long non-coding RNAs as crucial regulators are involved in cancer progression. However, the role of exosomal lncRNA LINC00662 in the development of NSCLC remains unclear.
View Article and Find Full Text PDFArticle Synopsis
- Researchers studied a tiny molecule called miR-4262 in patients with esophageal cancer to see how it affects their health and cancer development.
- They found that lower levels of miR-4262 in cancer samples were linked to worse disease stages and outcomes for patients.
- Increasing miR-4262 in cancer cells helped slow down their growth and caused more of them to die, suggesting it could be important for treating esophageal cancer.